3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
438
Triple Negative Breast Neoplasms
50
Neoplasm Metastasis
24
Ovarian Neoplasms
23
Carcinoma, Non-Small-Cell Lung
23
Lung Neoplasms
22
Colorectal Neoplasms
18
Carcinoma, Intraductal, Noninfiltrating
18
Neoplasms
16
Pancreatic Neoplasms
14
Prostatic Neoplasms
13
Brain Neoplasms
13
Stomach Neoplasms
12
Colonic Neoplasms
11
Breast Neoplasms, Male
10
Urinary Bladder Neoplasms
8
Small Cell Lung Carcinoma
8
Melanoma
8
Fatigue
8
Breast Carcinoma In Situ
8
Sarcoma
7
Squamous Cell Carcinoma of Head and Neck
6
Lymphedema
6
Head and Neck Neoplasms
6
Fallopian Tube Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Breast Cancer Female
6
Testicular Neoplasms
5
Pain
5
Esophageal Neoplasms
5
Interventions
brigimadlin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Tertiary Lymphoid Structures
×
Breast
×
Clear all
NCT06084689
2025-09-02
EMPIRE
Institut Bergonié
Phase 2
Withdrawn